Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopaMARSDEN, C. D.Drugs (Basel). 1998, Vol 55, pp 17-22, issn 0012-6667, SUP1Conference Paper

Parkinson's diseaseMARSDEN, C. D.Journal of neurology, neurosurgery and psychiatry. 1994, Vol 57, Num 6, pp 672-681, issn 0022-3050Article

Parkinson's disease in twinsMARSDEN, C. D.Journal of neurology, neurosurgery and psychiatry. 1987, Vol 50, Num 1, pp 105-106, issn 0022-3050Article

Parkinson's diseaseMARSDEN, C. D.Lancet (British edition). 1990, Vol 335, Num 8695, pp 948-952, issn 0140-6736Article

Cabergoline: advantages of sustained dopaminergic stimulationMARSDEN, C. D.Drugs (Basel). 1998, Vol 55, issn 0012-6667, 34 p., SUP1Conference Proceedings

Clinical relevance of neuropeptide researchMARSDEN, C. D.Progress in brain research. 1986, Vol 66, pp 369-374, issn 0079-6123Article

Hysteria ― a neurologist's viewMARSDEN, C. D.Psychological medicine (Print). 1986, Vol 16, Num 2, pp 277-288, issn 0033-2917Article

Parkinson's diseaseMARSDEN, C. D.Postgraduate medical journal. 1992, Vol 68, Num 801, pp 538-543, issn 0032-5473Article

Motor disorders in basal ganglia diseaseMARSDEN, C. D.Human neurobiology. 1984, Vol 2, Num 4, pp 245-250, issn 0721-9075Article

Bradykinesia and impairment of EEG desynchronization in Parkinson's diseaseBROWN, P; MARSDEN, C. D.Movement disorders. 1999, Vol 14, Num 3, pp 423-429, issn 0885-3185Article

A double blind trial of sulpiride in Huntington's disease and tardive dyskinesiaQUINN, N; MARSDEN, C. D.Journal of neurology, neurosurgery and psychiatry. 1984, Vol 47, Num 8, pp 844-847, issn 0022-3050Article

Trunk and head tremor as isolated manifestations of dystoniaRIVEST, J; MARSDEN, C. D.Movement disorders. 1990, Vol 5, Num 1, pp 60-65, issn 0885-3185Article

Personality in torticollis: a controlled studyJAHANSHAHI, M; MARSDEN, C. D.Psychological medicine (Print). 1988, Vol 18, Num 2, pp 375-387, issn 0033-2917Article

Rhythmic cortical and muscle discharge in cortical myoclonusBROWN, P; MARSDEN, C. D.Brain. 1996, Vol 119, pp 1307-1316, issn 0006-8950, 4Article

Psychological functioning before and after treatment of torticollis with botulinum toxinJAHANSHAHI, M; MARSDEN, C. D.Journal of neurology, neurosurgery and psychiatry. 1992, Vol 55, Num 3, pp 229-231, issn 0022-3050Article

The stiff man and stiff man plus syndromesBROWN, P; MARSDEN, C. D.Journal of neurology. 1999, Vol 246, Num 8, pp 648-652, issn 0340-5354Article

What do the basal ganglia do?BROWN, P; MARSDEN, C. D.Lancet (British edition). 1998, Vol 351, Num 9118, pp 1801-1804, issn 0140-6736Article

Depression in torticollis: a controlled studyJAHANSHAHI, M; MARSDEN, C. D.Psychological medicine (Print). 1988, Vol 18, Num 4, pp 925-933, issn 0033-2917Article

Limb apraxias: Higher-order disorders of sensorimotor integrationLEIGUARDA, R. C; MARSDEN, C. D.Brain. 2000, Vol 123, pp 860-879, issn 0006-8950, 5Article

SSRI-induced reversal of levodopa benefit in two patients with dopa-responsive dystoniaMATHEN, D; MARSDEN, C. D; BHATIA, K. P et al.Movement disorders. 1999, Vol 14, Num 5, pp 874-876, issn 0885-3185Article

Altered motor function and graft survival produced by basic fibroblast growth factor in rats with 6-OHDA lesions and fetal ventral mesencephalic grafts are associated with glial proliferationZENG, B.-Y; JENNER, P; MARSDEN, C. D et al.Experimental neurology (Print). 1996, Vol 139, Num 2, pp 214-226, issn 0014-4886Article

Mitochondrial respiratory enzyme function and superoxide dismutase activity following brain glutathione depletion in the ratSEATON, T. A; JENNER, P; MARSDEN, C. D et al.Biochemical pharmacology. 1996, Vol 52, Num 11, pp 1657-1663, issn 0006-2952Article

Neurological sequelae following carbon monoxide poisoning clinical course and outcome according to the clinical types and brain computed tomography scan findingsLEE, M. S; MARSDEN, C. D.Movement disorders. 1994, Vol 9, Num 5, pp 550-558, issn 0885-3185Article

Autoradiographic study of striatal D₁ and D₂ dopamine receptors in 5-OHDA-lesioned rats receiving foetal ventral mesencephalic grafts and chronic treatment with L-DOPA and carbidopaBLUNT, S. B; JENNER, P; MARSDEN, C. D et al.Brain research. 1992, Vol 582, Num 2, pp 299-311, issn 0006-8993Article

Motor function, graft survival and gliosis in rats with 6-OHDA lesions and foetal ventral mesencephalic grafts chronically treated with L-DOPA and carbidopaBLUNT, S. B; JENNER, P; MARSDEN, C. D et al.Experimental brain research. 1992, Vol 88, Num 2, pp 326-340, issn 0014-4819Article